Steven J Edwards

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis
    S J Edwards
    Outcomes Research, AstraZeneca, Kings Langley, UK
    Aliment Pharmacol Ther 15:1729-36. 2001
  2. ncbi Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials
    Steven J Edwards
    AstraZeneca UK Ltd, Luton, United Kingdom
    Clin Ther 31:1345-59. 2009
  3. ncbi Systematic review and meta-analysis of budesonide/formoterol in a single inhaler
    Steven J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Curr Med Res Opin 23:1809-20. 2007
  4. ncbi Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, UK
    Int J Clin Pract 64:619-27. 2010
  5. ncbi Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Aliment Pharmacol Ther 24:743-50. 2006
  6. ncbi Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care
    Steven J Edwards
    AstraZeneca UK Ltd, Luton, UK
    Eur J Health Econ 7:72-8. 2006
  7. ncbi Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections
    Steven J Edwards
    Outcomes Research Department, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Curr Med Res Opin 21:785-94. 2005
  8. ncbi A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis
    Anan S Raghunath
    St. Andrews Group Practice, Hull, Luton, United Kingdom
    Clin Ther 25:2088-101. 2003
  9. ncbi Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials
    Joe Gray
    AstraZeneca UK Ltd, Luton, UK
    Curr Med Res Opin 26:537-47. 2010
  10. ncbi Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, UK
    Aliment Pharmacol Ther 30:547-56. 2009

Detail Information

Publications12

  1. ncbi Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis
    S J Edwards
    Outcomes Research, AstraZeneca, Kings Langley, UK
    Aliment Pharmacol Ther 15:1729-36. 2001
    ..Esomeprazole is a new proton pump inhibitor, which has been compared to omeprazole for the treatment of reflux oesophagitis in clinical trials...
  2. ncbi Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials
    Steven J Edwards
    AstraZeneca UK Ltd, Luton, United Kingdom
    Clin Ther 31:1345-59. 2009
    ..This article reviews and compares the tolerability profiles of atypical antipsychotics in adults with schizophrenia or bipolar disorder in randomized controlled trials (RCTs)...
  3. ncbi Systematic review and meta-analysis of budesonide/formoterol in a single inhaler
    Steven J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Curr Med Res Opin 23:1809-20. 2007
    ..To compare the effectiveness of budesonide/formoterol using fixed dosing (BUD/FORM) with inhaled corticosteroid (ICS) alone or alternative ICS and long-acting beta(2)-agonist (LABA) regimens for adults with moderate/severe asthma...
  4. ncbi Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, UK
    Int J Clin Pract 64:619-27. 2010
    ....
  5. ncbi Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Aliment Pharmacol Ther 24:743-50. 2006
    ..No randomized controlled trial has compared all the licensed standard dose proton pump inhibitors in the healing of reflux oesophagitis...
  6. ncbi Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care
    Steven J Edwards
    AstraZeneca UK Ltd, Luton, UK
    Eur J Health Econ 7:72-8. 2006
    ..62) and more effective (0.084, 95% CI 0.023 to 0.144). Meropenem thus appears significantly more effective and less expensive than imipenem plus cilastatin and should therefore be considered the dominant treatment strategy...
  7. ncbi Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections
    Steven J Edwards
    Outcomes Research Department, AstraZeneca UK Ltd, Luton, Bedfordshire, UK
    Curr Med Res Opin 21:785-94. 2005
    ..To compare the effectiveness of meropenem with imipenem plus cilastatin in the treatment of severe infections...
  8. ncbi A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis
    Anan S Raghunath
    St. Andrews Group Practice, Hull, Luton, United Kingdom
    Clin Ther 25:2088-101. 2003
    ..CONCLUSION: The currently available comparative data for esomeprazole and lansoprazole indicate clinical and cost-effectiveness advantages for esomeprazole in the healing and maintenance of erosive esophagitis compared with lansoprazole...
  9. ncbi Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials
    Joe Gray
    AstraZeneca UK Ltd, Luton, UK
    Curr Med Res Opin 26:537-47. 2010
    ..However, the incremental benefit and risk of increasing through the licensed dose range have not been comprehensively assessed across all available clinical trials...
  10. ncbi Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials
    S J Edwards
    Outcomes Research, AstraZeneca UK Ltd, Luton, UK
    Aliment Pharmacol Ther 30:547-56. 2009
    ..No randomized controlled trial (RCT) has compared all European-licensed standard- and double-dose PPIs for the healing of severe erosive oesophagitis...
  11. ncbi Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis
    Gregory Y H Lip
    Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK
    Thromb Res 118:321-33. 2006
    ..To compare the effectiveness of aspirin, warfarin, and ximelagatran as thromboprophylaxis in patients with non-valvular atrial fibrillation (NVAF)...
  12. ncbi Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials
    Gregory Boustead
    Department of Urology, Lister Hospital, Stevenage, UK
    BJU Int 99:1383-9. 2007
    ....